A new continuous OC that eliminates menstruation throughout the entire year has been shown to improve dysmenorrhea in a 1-year clinical trial presented at this year's ASRM meeting in Montreal.
A new continuous OC that eliminates menstruation throughout the entire year has been shown to improve dysmenorrhea in a 1-year clinical trial presented at this year's ASRM meeting in Montreal. The phase 3 study evaluated the effects of 20 μg of ethinyl estradiol and 90 μg of levonorgestrel in healthy women between the ages of 18 and 49 with a history of cycle-related symptoms, PMS, or dysmenorrhea. The OC significantly improved symptoms and boosted work productivity.
The researchers, who were supported by a grant from Wyeth, also concluded that the OC was more effective than selective serotonin reuptake inhibitors in treating PMS.
A related study, in which investigators did endometrial biopsies on the same group of women at baseline and 13 months into the trial, found that "histologic changes ....were consistent with a decrease in endometrial growth and decidualization."
Johnson JV, Grubb GS. Endometrial histology in subjects on a continuous use regimen of levo-norgestrel/ethinyl estradiol: results of a Phase 3 study. Fertil Steril. 2005;84(suppl 1):S170.
Regulatory T cell alterations in early pregnancy linked to spontaneous preterm labor
February 18th 2025A recent study reveals that specific Treg subpopulation changes in the first trimester may contribute to spontaneous preterm labor, shedding light on the role of immune regulation in pregnancy outcomes.
Read More
Late third-trimester ultrasound accurately predicts large for gestational age births
February 17th 2025A new study confirms that estimating fetal weight with ultrasound between 35 to 38 weeks’ gestation strongly predicts large for gestational age births, helping guide clinical management decisions.
Read More